MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. The industry also encourages the development of novel pharmaceuticals and treatments, creating opportunities for Maryland residents to access cutting-edge healthcare options.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

AUGUST 17, 2021

.–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. The Phase 2 TSC trial, the CALM trial, was an open-label trial to evaluate the safety and tolerability of adjunctive ganaxolone treatment in patients with seizures associated with TSC. About Marinus Pharmaceuticals.

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Veriheal

SEPTEMBER 7, 2022

implemented a revolutionary emergency amendment to its medical cannabis program. ’s Medical Cannabis Program. Without new emergency legislation or more permanent action, the program expansion will expire on Feb. ’s medical program to its limits is viewed as a stopgap until federal reform enables D.C.

Patients 97

Patients Programs Access Treatment 97

Cannabis Law Report

DECEMBER 5, 2021

Funders are endorsing MAPS’ mission and pursuit of mass mental health backed by 35 years of innovative leadership, governance, programs, and strategies. Getting MAPS out ahead of the industry will create a commercial and cultural bar that puts patient access first.”.

Therapy 52

Therapy Access Research and Development Clinical Trials 52

NORML

FEBRUARY 23, 2020

Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. Send a message to your lawmakers in support of medical marijuana access. AL resident? NH resident? OK resident?

Legislation 242

Legislation Patients Decriminalization Access 242

Project CBD

AUGUST 23, 2023

Earlier this year, the Food & Drug Administration disclosed that it would not regulate non-pharmaceutical CBD products, thereby putting the onus on Congress to devise an appropriate regulatory framework for cannabidiol and other hemp-derived cannabinoids. Caffeine can also be found in pharmaceutical 33 and non-pharmaceutical products.)

Cannabinoids 141

Cannabinoids Hemp THC Safety 141

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. “Our Work with U.S.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

NORML

AUGUST 26, 2019

So, it shouldn’t be a huge surprise that Virginia didn’t launch a medical marijuana program until 2015, nearly two decades after California. And it took extensive, concerted efforts from marijuana law reform organizations like NORML to negotiate with Virginia’s Republican Party to get the program finally running.

Marijuana 213

Marijuana Legalization Programs Oil 213

Veriheal

MAY 17, 2021

Many of them even offer the ability for visiting medical cannabis patients from other states to participate in their programs. Other states have gone beyond just medical access and have also legalized retail cannabis markets for adult consumers. That is perhaps the biggest lie that is being perpetuated on the Alabama public today.

Legalization 86

Legalization Pharmaceutical Therapy Chronic Pain 86

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This relationship enables us to initiate our clinical research program and marks an important step for Wake in Canada. ABOUT SANTÉ CANNABIS.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

The Cannigma

MARCH 25, 2021

A United Kingdom police chief proposed a novel idea this January: Allow drug-dependent inmates access to free cannabis to help them overcome opioid addiction. This creates a situation where state detention facilities — even where cannabis is legal — do not allow inmates access to medical cannabis because it violates federal law.

Marijuana 145

Marijuana Access Law Pharmaceutical 145

Cannabis Law Report

OCTOBER 21, 2021

adults shows broad support for securely labeling cannabis products to verify their legitimacy and safety in the marketplace. Ensuring the safety of cannabis products is top of mind for Americans. Four in five Americans (80% ) voiced their support for a program that would make it easier to detect legal vs. illegal cannabis products.

Safety 52

Safety Research and Development Compliance Compliance 52

NORML

FEBRUARY 29, 2020

Legislation is pending, House Bill 268 and House Bill 528, to allow those convicted of simple marijuana possession to petition the court to restrict access to their records. Send a message to your lawmakers in support of access to edibles. Send a message to your governor in support of a state-legal medical cannabis program.

Legislation 146

Legislation Decriminalization Patients Edibles 146

Cannabis Law Report

MAY 28, 2019

Veterans Struggle to Gain Access to Medical Marijuana. Thirty-three states and the District of Columbia have enacted medical marijuana programs. Despite this expansion military veterans often face greater obstacles to gaining access to medical marijuana than other groups. Current Issues in Marijuana Regulation. May 2, 2019.

Access 49

Access Marijuana Research and Development Programs 49

MMJ Recs

APRIL 1, 2024

Its non-addictive nature and minimal side effects make it an attractive alternative to conventional pharmaceuticals for many individuals seeking natural remedies. CBD Oil for Medical Conditions CBD oil has gained popularity as a versatile and accessible option for managing various medical conditions.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Cannabis Law Report

MAY 8, 2022

I have an extensive background in healthcare and have worked in the community, aged care and palliative care sectors as well the corporate (pharmaceutical and insurance) sectors. Introduce public health education and awareness programs about the preventative benefits of cannabis and hemp as a plant-based diet and medicine.

Education 98

Education Medicine Cannabinoids Programs 98

NORML

JANUARY 25, 2019

179: The VA Medicinal Cannabis Research Act of 2019 to facilitate federally-sponsored clinical research into the safety and efficacy of medical cannabis among veterans. Legislation is pending, House Bill 1150, to expand the state’s nascent medical cannabis access law. HI resident? IA resident? MO resident? North Dakota.

Legislation 153

Legislation Patients Oil Hemp 153

Cannabis Law Report

JUNE 9, 2022

11:00-12:00 PM: Interstate Commerce: Impacts on markets, licensing, and consumer safety. Steph Sherer, Founder and President, Americans for Safe Access. Panelists: David Crawford, Senior Program Manager, Code for America. Katie Mueller, Senior Program Manager, National Safety Council. Cannabis Council.

Policy 52

Policy Safety Seed-To-Sale Data 52

Cannabis Law Report

DECEMBER 2, 2021

Recommendations and rulemaking relating to training and products were placed on an expedited timeline to ensure that facilitators will be trained, and products will be ready for the January 2, 2023, launch of the first state-sponsored psilocybin therapy program in the United States. Core Psilocybin Facilitation Skills (16 Hours).

Law 52

Law Programs Therapy Education 52

Cannabis Law Report

NOVEMBER 3, 2021

In parallel, we are working to make our extracts for inhalation accessible to patients in other countries on the continent as well as to register them in the appropriate regulatory tracks.”. Going forward, our collaboration with Panaxia will allow us to further develop our product offering and provide medical cannabis to promising markets.”.

Extraction 52

Extraction Pharmaceutical Patients Treatment 52

NORML

FEBRUARY 1, 2019

Legislation has been reintroduced from last year, Senate Bill 34, which would exempt compassionate care programs from paying state cannabis taxes when they are providing free medical cannabis to financially disadvantaged people living with serious health conditions. Click here to email your lawmakers in support of banking access.

Legislation 166

Legislation Decriminalization Access Patients 166

Cannabis Law Report

JANUARY 19, 2022

AMP has entered into a three-year exclusive pharmaceutical distribution agreement for LGP Classic full-plant cannabis extract oils. Waldhausklinik is a non-profit acute care hospital for internal medicine in the Free State of Bavaria and has entered into a research collaboration with AMP into the efficacy and safety of medical cannabis.

Extraction 52

Extraction Oil Research and Development Medicine 52

Cannabis Law Report

JULY 19, 2021

We are in a mental health crisis and its critical to ensure that we conduct clinical trials to demonstrate safety, and efficacy up to and including phase 3 large scale clinical trials. Extensive early phase experience with appropriate safety oversight and early phase clinic.

Clinical Trials 98

Clinical Trials Research and Development Hybrid Medicine 98

The Cannigma

AUGUST 26, 2021

Australia has a legal medical marijuana program, and while recreational cannabis remains illegal on the federal level, the enforcement of cannabis laws and the penalties handed out can differ widely from one territory to another. This also means that the TGA has not accessed these medicines for their safety, quality, or effectiveness.

Legalization 52

Legalization Access Medicine Clinical Trials 52

SpeedWeed

AUGUST 26, 2021

Aurora Germany GmbH, partnered with Ethypharm to deliver the first shipment of cannabis medicine to France to be used in the country’s medical cannabis pilot program. Both Aurora and Ethypharm were chosen by the National Agency for Safety Medicines and Health Products (ANSM) to deliver dried flower for use by French patients.

Chronic Pain 52

Chronic Pain Programs Patients Medicine 52

The Joint Blog

JUNE 2, 2020

The study, titled Pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial , was first published by NORML. Pain intensity and safety parameters were recorded on a 10-cm visual analogue scale (VAS) at pre-defined time points.

Chronic Pain 58

Chronic Pain Clinical Trials Safety Marijuana 58

Cannabis Law Report

JANUARY 3, 2022

CBD Product Safety and Standardization Act of 2021. The most recent legislation to debut on behalf of hemp, the CBD Product Safety and Standardization Act of 2021, was introduced this month by a bipartisan group of U.S. Hemp Access and Consumer Safety Act. representatives, including Reps. Hemp champion Sen.

Hemp 52

Hemp Packaging Banking Food 52

Cannabis Law Report

JULY 24, 2021

At Mydecine, we are excited to expand our drug development program to include the improvement of entactogenic compounds,” said Rob Roscow, Chief Scientific Officer.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

Veriheal

NOVEMBER 10, 2020

The experiment will allow participating companies to import cannabis and the companies who wish to participate in the experiment will be obliged to give participants free medical cannabis which has to comply with the pharmaceutical standards and good manufacturing practice. .

Chronic Pain 76

Chronic Pain Pharmaceutical Patients Epilepsy 76

Cannabis Law Report

SEPTEMBER 12, 2022

Our mushrooms are some of the most tested products on the planet as we cross the lines between Pharmaceutical, Agriculture, Botanical, and Food testing quality assays,” said Optimi Chief Science Officer, Justin Kirkland. To access a complete photo gallery of this historic grow, please click here. Penis Envy. Blue Pulaski.

History 52

History Clinical Trials Legalization Research and Development 52

NORML

JANUARY 11, 2019

At the state level, Governor Jay Inslee of Washington launched a new program and began granting pardons to those with past criminal misdemeanor marijuana-related convictions on their record. Legislation is pending, House Bill 1272, to expand access to medical cannabis in North Dakota. ND resident? NH resident? NH resident? NH resident?

Legislation 195

Legislation Decriminalization Hemp Patients 195

Cannabis Law Report

JANUARY 24, 2020

Hemp Industry Daily reports…… Another product has been approved for use under Ireland’s Medical Cannabis Access Programme (MCAP). Last year , Ireland’s Minister for Health signed legislation to commence a medical cannabis program that is to operate on a pilot basis for five years. It contains 9.6

Oil 59

Oil Epilepsy Conditions Treatment 59

Cannabis Law Report

JUNE 1, 2021

Steve Barbera to Vice President, Market Access. I am thrilled to have Patricia, Steve, Julie and Dewey join us to help accelerate our capabilities across these key functions,” said Dr. Drake received her bachelor’s degree from Wichita State University and is a graduate of the Harvard Business School Executive Leadership Program.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Cannabis Law Report

JANUARY 21, 2019

“There is significant real-world and clinical evidence supporting the safety and effectiveness of cannabis-based medicinal products,” said said Dr. Mark Ware, chief medical officer at Canopy. It will begin by lobbying UK patient groups and doctors and launching a physician education program to open research to UK docs.

Chronic Pain 72

Chronic Pain Medicine Education Patients 72

SpeedWeed

JULY 8, 2021

Michigan and Massachusetts continue to make strong showings as their programs continue to grow. . Manufacturers have the best opportunity to build a brand, and this makes it an attractive part of the value chain for transplanted talent from liquor, packaged goods, and pharmaceuticals because it seems familiar. .

Media 52

Media Data Retail Concentrates 52

Veriheal

AUGUST 31, 2020

Program between St. About Sinibaldo: Sinibaldo is an aspiring healthcare professional and a biomedical researcher in the Medical Scientist Training Program (M.D./Ph.D.) About Nishtha: Nishtha is pursuing neurology to become a physician-scientist in honor of her grandmother Nani who suffered from Alzheimer’s.

Research and Development 117

Research and Development Education Agriculture Patients 117

The Cannigma

FEBRUARY 1, 2023

Advocate for the rescheduling of cannabis to improve access to cannabis for research purposes, and scientific funding for novel cannabinoid-based cancer therapies. 36 Synthetic (pharmaceutical) cannabinoids and cancer Scientists did not rest when they learned that cannabis and cannabinoids may have anti cancer properties.

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145